Tanomed Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $2.29M
Latest Deal Amount

Tanomed General Information

Description

Provider of drugs for preventing colds. The company develops Tango and Tango Nasal which treats, relieves and prevents colds, in which glucose oxidase is used in combination with glucose to effectively counteract rhinovirus infections as well as other viral and bacterial pathogens.

Contact Information

Website
www.tanomed.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Primary Office
  • PO BOX 7994
  • 907 19 Umeå
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tanomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Apr-2015 $2.29M 00.000 Completed Startup
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Tanomed’s complete valuation and funding history, request access »

Tanomed Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
Partnerinvest Norr Venture Capital Minority 000 0000 000000 0
Umeå Biotech Incubator Accelerator/Incubator Minority 000 0000 000000 0
To view Tanomed’s complete investors history, request access »